At the end-stage of cancer, Treg cell numbers had increased about 1.5-fold in B16F10-treated Prnp+/+ and Tga20 mice compared to untreated control mice; however, there was no increase in Prnp0/0 mice. The gene discussed is PRNP; the disease is cancer.